HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether compared to our standard low dose ATG with
CSA, the high dose ATG with low-dose CSA minimizes the chances of relapse and chronic GVHD,
without increasing the chances of other transplant complications.